cAMP analogues downregulate the expression of granulocyte macrophage colony-stimulating factor (GM-CSF) in human bone marrow stromal cells in vitro.

Por Bug, G, Aman, J, Huber, C, Peschel, C, Derigs, H G
Publicado em 1998

Antagonism between granulocytic maturation and deacetylase inhibitor-induced apoptosis in acute promyelocytic leukaemia cells

Por Hennig, D, Müller, S, Wichmann, C, Drube, S, Pietschmann, K, Pelzl, L, Grez, M, Bug, G, Heinzel, T, Krämer, O H
Publicado no Br J Cancer (2015)

Phase I/II study of the deacetylase inhibitor panobinostat after allogeneic stem cell transplantation in patients with high-risk MDS or AML (PANOBEST trial)

Por Bug, G, Burchert, A, Wagner, E-M, Kröger, N, Berg, T, Güller, S, Metzelder, S K, Wolf, A, Hünecke, S, Bader, P, Schetelig, J, Serve, H, Ottmann, O G
Publicado no Leukemia (2017)

Sequential combination of azacitidine and lenalidomide in del(5q) higher-risk myelodysplastic syndromes or acute myeloid leukemia: a phase I study

Por Platzbecker, U, Braulke, F, Kündgen, A, Götze, K, Bug, G, Schönefeldt, C, Shirneshan, K, Röllig, C, Bornhäuser, M, Naumann, R, Neesen, J, Giagounidis, A, Hofmann, W-K, Ehninger, G, Germing, U, Haase, D, Wermke, M
Publicado em 2013